The Effect of Device Closure of Patent Foramen Ovale in Elderly Patients With Crytogenic Stoke/TCI

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The primary objective is to evaluate if patent foramen ovale (PFO) closure and antiplatelet medical management can reduce the risk of recurrent stroke or transient ischemic attack (TIA) when compared to antiplatelet medical management alone in elderly patients above 50 years of age with a PFO and a history of cryptogenic stroke or TIA.
Epistemonikos ID: 7ba1afce01a271854fc56b364d39658a09737e2d
First added on: May 05, 2024